Skip to main content

Table 1 Baseline characteristics at enrollment of study children by study site

From: Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy

Site

Mut

Yao

Gar

Drug Groups

SPAQ

SP

AQ

SPAQ

SP

AQ

SPAQ

SP

AQ

Age (mean in months ± SD)

29 ± 15.5

27 ± 14.8

27 ± 15.2

29.4 ± 14.5

30 ± 15.1

29 ± 13.8

27 ± 15.4

26.6 ± 16.5

27.4 ± 17.2

Female/Male ratio

1

0.9

1

0.7

1.2

0.82

0.74

0.82

1.2

Weight (kg) (mean ± SD)

12.5 ± 3.5

12.2 ± 3.2

12.2 ± 4.1

13.02 ± 3.0

12.6 ± 3.4

12.9 ± 3.2

10.84 ± 3.3

10.86 ± 2.7

10.59 ± 3.3

Geo mean parasitemia (± SD)

39601

(± 48160)

27014

(± 49560)

22072

(± 30260)

7776

(± 27120)

6721

(± 25200)

5364

(± 25720)

7264

(± 27730)

5668

(± 19040)

6294

(± 26890)

Temp °C (mean ± SD)

38.9 ± 1.1

38.7 ± 1.1

38.7 ± 1.0

38.2 ± 1.2

38.3 ± 1.0

38.4 ± 1.2

37.9 ± 0.6

38.0 ± 0.6

37.7 ± 0.7

  1. A, B, C, were groups to which independently at each site drugs were randomly assigned. SP- Sulphadoxine-pyrimethamine, AQ - Amodiaquine, SPAQ- combination of AQ and SP, SD- Standard Deviation. Ecotypes; Mutengene (Mut) is in the littoral-forest, Yaoundé (Yao) is in the forest-savannah mosaic and Garoua (Gar) is in the guinnea-savannah